111 Inc (YI)
1.00
+0.03
(+3.08%)
USD |
NASDAQ |
Apr 18, 16:00
1.00
0.00 (0.00%)
After-Hours: 20:00
111 Debt to Equity Ratio: -0.6806 for Sept. 30, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2023 | -0.6806 |
| June 30, 2023 | -0.6943 |
| March 31, 2023 | -0.6373 |
| December 31, 2022 | -0.4317 |
| September 30, 2022 | -0.6196 |
| June 30, 2022 | -0.8206 |
| March 31, 2022 | -1.019 |
| December 31, 2021 | -1.498 |
| September 30, 2021 | -1.367 |
| June 30, 2021 | 0.8891 |
| March 31, 2021 | 0.1784 |
| December 31, 2020 | 0.6414 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.3713 |
| June 30, 2020 | 0.2515 |
| March 31, 2020 | 0.0589 |
| December 31, 2019 | 0.1224 |
| September 30, 2019 | 0.098 |
| June 30, 2019 | 0.0359 |
| March 31, 2019 | 0.018 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | |
| December 31, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.498
Minimum
Dec 2021
0.8891
Maximum
Jun 2021
-0.2845
Average
-0.1979
Median
Debt to Equity Ratio Benchmarks
| Concord Medical Services Holdings Ltd | -- |
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | 0.7819 |
| Zai Lab Ltd | 0.00 |
| I-MAB | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 460.64M |
| Total Liabilities (Quarterly) | 417.44M |
| Shareholders Equity (Quarterly) | -70.35M |
| Current Ratio | 1.072 |
| Net Debt Paydown Yield | -0.85% |